Summary Safety Review - SGLT2 inhibitors - Assessing the potential risk of a rare brain condition (posterior reversible encephalopathy syndrome) in patients who have developed high levels of acids in the blood (diabetic ketoacidosis) - Summary Safety Review - SGLT2 inhibitors - Assessing the potential risk of a rare brain condition (posterior reversible encephalopathy syndrome) in patients who have developed high levels of acids in the blood (diabetic ketoacidosis)

Additional Information

Field	Value
Data last updated	October 20, 2025
Metadata last updated	October 20, 2025
Created	October 20, 2025
Format	HTML
License	Open Government Licence - Canada
Has views	False
Id	2b44dd30-f5e4-4cd5-bc58-2ea7513027d4
Package id	1bbd6bd6-5383-4a4c-a0f8-c2213c159197
Position	1
State	active